Next-generation sequencing technology for diagnosis and efficacy evaluation of a patient with visceral leishmaniasis: A case report

Table 1 Changes in patient laboratory indicators

Days of illness	WBC, 109/L	PLT, 109/L	Hb, g/L	LY, %	GLO, g/L
Day 1	1.69	30	84	49.70	77.00
Day 18	3.96	127	98	58.30	83.00
Day 41	7.37	49	112	65.40	99.90
Day 66	6.34	280	95	62.80	103.10
Day 88	6.70	450	109	44.90	97.00
Day 151	8.57	377	138	44.10	58.20
Day 186	8.57	429	138	45.90	49.00
Day 221	9.04	427	148	43.80	43.40
Day 289	9.40	372	136	41.00	36.30
Normal range	3.50-9.50	125-350	130-175	20.00-50.00	20.00-40.00

GLO: Globulin; Hb: Hemoglobin; LY: Lymphocyte percentage; PLT: Platelets; WBC: White blood cells.